CD5 and diffuse large B-cell lymphoma: In summary, our FCM-based study provided novel information about the proportion of non-CD5-T-cell marker-positive B-cell lymphomas, diagnosed according to the current WHO classification, and their prognostic significance in patients with DLBCL.